Syschem India [SYSCHEM] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Syschem India

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syschem India wins in 6 metrics, Sun Pharmaceutical wins in 13 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSyschem IndiaSun PharmaceuticalBetter
P/E Ratio (TTM)122.9837.73Sun Pharmaceutical
Price-to-Book Ratio2.555.42Syschem India
Debt-to-Equity Ratio0.003.26Syschem India
PEG Ratio0.11-1.94Sun Pharmaceutical
EV/EBITDA45.4923.98Sun Pharmaceutical
Profit Margin (TTM)0.49%19.29%Sun Pharmaceutical
Operating Margin (TTM)1.35%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)1.35%24.34%Sun Pharmaceutical
Return on Equity0.50%15.08%Sun Pharmaceutical
Return on Assets (TTM)0.21%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$-318.13M$119.44BSun Pharmaceutical
Dividend YieldN/A1.26%N/A
1-Year Return37.95%-13.08%Syschem India
Price-to-Sales Ratio (TTM)0.607.28Syschem India
Enterprise Value$2.55B$3,678.87BSun Pharmaceutical
EV/Revenue Ratio0.626.84Syschem India
Gross Profit Margin (TTM)5.24%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$104$224Sun Pharmaceutical
Earnings per Share (Diluted)$0.46$43.23Sun Pharmaceutical
Beta (Stock Volatility)-0.830.28Syschem India
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Syschem India vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Syschem India
Sun Pharmaceutical
Syschem India Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syschem India-0.02%2.33%2.45%22.19%53.40%14.59%
Sun Pharmaceutical-0.10%3.69%4.56%-1.60%-0.80%-12.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syschem India37.95%19.58%816.69%354.66%274.57%46.91%
Sun Pharmaceutical-13.08%69.32%239.52%85.64%710.50%2,595.42%

News Based Sentiment: Syschem India vs Sun Pharmaceutical

Syschem India

News based Sentiment: MIXED

Syschem India Ltd. showed both positive and negative developments in early October 2025. While the stock outperformed its sector and experienced price increases, the decline in delivery volume raises concerns about future trading activity and investor interest. This mixed performance warrants a cautious outlook.

View Syschem India News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a month of significant contrasts for Sun Pharma. While the company demonstrated revenue growth and made strategic acquisitions, the imposition of a 100% US tariff on Indian pharmaceuticals presents a major headwind. This combination of positive and negative developments creates a mixed investment outlook.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Syschem India vs Sun Pharmaceutical

MetricSYSCHEMSUNPHARMA
Market Information
Market Cap i₹2.50B₹4.01T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i41,7213,168,435
90 Day Avg. Volume i80,2822,778,768
Last Close₹56.56₹1,653.10
52 Week Range₹35.33 - ₹62.00₹1,548.00 - ₹1,947.00
% from 52W High-8.77%-15.10%
All-Time High₹149.00 (Mar 03, 2003)₹1,960.35 (Sep 30, 2024)
% from All-Time High-62.04%-15.67%
Growth Metrics
Quarterly Revenue Growth0.24%0.10%
Quarterly Earnings Growth11.24%-0.20%
Financial Health
Profit Margin (TTM) i0.00%0.19%
Operating Margin (TTM) i0.01%0.24%
Return on Equity (TTM) i0.01%0.15%
Debt to Equity (MRQ) i0.003.26
Cash & Liquidity
Book Value per Share (MRQ)₹22.21₹300.99
Cash per Share (MRQ)₹0.49₹108.88
Operating Cash Flow (TTM) i₹-314,030,000₹110.84B
Levered Free Cash Flow (TTM) i₹4.60M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A1.26%
Last 12-Month Dividend iN/A₹21.00

Valuation & Enterprise Metrics Analysis: Syschem India vs Sun Pharmaceutical

MetricSYSCHEMSUNPHARMA
Price Ratios
P/E Ratio (TTM) i122.9837.73
Forward P/E iN/A49.91
PEG Ratio i0.11-1.94
Price to Sales (TTM) i0.607.28
Price to Book (MRQ) i2.555.42
Market Capitalization
Market Capitalization i₹2.50B₹4.01T
Enterprise Value i₹2.55B₹3.68T
Enterprise Value Metrics
Enterprise to Revenue i0.626.84
Enterprise to EBITDA i45.4923.98
Risk & Other Metrics
Beta i-0.830.28
Book Value per Share (MRQ) i₹22.21₹300.99

Financial Statements Comparison: Syschem India vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SYSCHEMSUNPHARMA
Revenue/Sales i₹1.09B₹137.86B
Cost of Goods Sold i₹1.04B₹28.15B
Gross Profit i₹57.27M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹17.08M₹33.72B
EBITDA i₹24.69M₹47.66B
Pre-Tax Income i₹16.74M₹31.73B
Income Tax i₹0₹8.70B
Net Income (Profit) i₹16.74M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SYSCHEMSUNPHARMA
Cash & Equivalents i₹21.37M₹102.69B
Total Current Assets i₹1.61B₹526.24B
Total Current Liabilities i₹1.24B₹181.94B
Long-Term Debt i₹0₹3.58B
Total Shareholders Equity i₹912.88M₹724.86B
Retained Earnings i₹-106.44M₹578.62B
Property, Plant & Equipment i₹19.33M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SYSCHEMSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSYSCHEMSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i41,7213,168,435
Average Daily Volume (90 Day) i80,2822,778,768
Shares Outstanding i43.51M2.40B
Float Shares i17.35M1.06B
% Held by Insiders i0.64%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Syschem India vs Sun Pharmaceutical

MetricSYSCHEMSUNPHARMA
Last 12-Month Dividend iN/A₹21.00
Last 12-Month Dividend Yield iN/A1.26%
3-Year Avg Annual Dividend iN/A₹14.67
3-Year Avg Dividend Yield iN/A0.46%
3-Year Total Dividends iN/A₹44.00
Ex-Dividend DateN/AJul 07, 2025